Chenhao Liu

Chenhao Liu

Auto-generated profile, based on publicly available information

Chenhao Liu

Department of Orthopedics, Qinghai Provincial People’s Hospital, Xining, Qinghai, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
FZFeng Zheng
Feng Zheng
LCLinhai Cao
Linhai Cao
JFJiawei Fu
Jiawei Fu
MLMenglin Luo
Menglin Luo
WYWenbo Yue
Wenbo Yue
CLChenhao Liu
Chenhao Liu
Purpose: Intervertebral disc degeneration (IVDD), a common degenerative disorder, is characterized by chronic inflammation and progressive cell death. PANoptosis, an integrated form of programmed cell death that merges pyroptosis, apoptosis, and necroptosis, has recently emerged as a key contributor to degenerative diseases. Although Toll-like receptor 4 (TLR4) and NLRP12 are known to regulate inflammatory signaling and cell death, their roles in mediating annulus fibrosus cells (AFCs). This study investigated how the TLR4–NLRP12 axis regulates AFC PANoptosis and contributes to IVDD progression. Methods: Single-cell RNA sequencing (scRNA-seq) profiled cell heterogeneity and PANoptosis-related signaling in healthy/degenerative annulus fibrosus (AF) tissues. An in vitro IVDD model was established by treating AFCs with TNF-α to mimic inflammation. NLRP12 knockdown was performed via lentiviral transduction. PANoptosis was assessed by Western blot (cleaved-Caspase-1, cleaved-Caspase-3, p-MLKL, c-GSDMD), TUNEL staining, and flow cytometry. In vivo, a rat IVDD model was induced by acupuncture puncture, followed by TLR4 knockdown via lentiviral injection. X-ray imaging was used to assess intervertebral space height, histology to evaluate disc morphology, and TUNEL assay to detect annulus fibrosus cell death. Results: scRNA-seq revealed an increased abundance of Fibro-AFCs and Adh-AFCs in IVDD, alongside enrichment of cell death-related pathways. PANoptosis-related gene expression and cell death scores were elevated in degenerative samples. In vitro, TLR4 activation induced PANoptosis in AFCs, which was attenuated by either TLR4 inhibition or NLRP12 knockdown. Formation of the PANoptosome complex-characterized by colocalization of Caspase-8, ASC, and RIPK3-was observed in degenerative AFCs. In vivo, TLR4 silencing ameliorated IVDD pathology, as evidenced by improved disc height, and reduced cell death. To our knowledge, this is the first study to identify the occurrence of PANoptosis in AFCs. Conclusion: TLR4 promotes PANoptosis in AFCs through NLRP12 activation, driving IVDD pathogenesis. The TLR4-NLRP12-PANoptosis presents a potential therapeutic target for IVDD.

31 August 2026 in Biomaterials
Verified
Journal Article
Closed access
CLChao Liu
Chao Liu
LTLu Tan
Lu Tan
YZYu Zhai
Yu Zhai
YZYan Zheng
Yan Zheng
YWYanqiu Wang
Yanqiu Wang
CLChangqing Li
Changqing Li

3 April 2026 in Medicine
Verified
Journal Article
Open access
FZFeng Zheng
Feng Zheng
JFJiawei Fu
Jiawei Fu
ZHZhilei Hu
Zhilei Hu
MLMenglin Luo
Menglin Luo
WYWenbo Yue
Wenbo Yue
CLChenhao Liu
Chenhao Liu
Intervertebral disc degeneration (IDD) is a leading cause of chronic low back pain, yet the molecular mechanisms driving its progression remain incompletely defined. Emerging evidence suggests that endoplasmic reticulum stress and the unfolded protein response (UPR) may play critical roles in disc cell dysfunction. Transcriptomic datasets (GSE70362 and GSE56081) from human nucleus pulposus tissues were integrated to identify UPR-related differentially expressed genes. Functional enrichment, gene set enrichment analysis, and gene set variation analysis analyses were performed to explore associated biological pathways. Protein–protein interaction networks, transcription factor–target predictions, and immune infiltration analyses were conducted. Two-sample Mendelian randomization was applied to assess potential causal relationships between UPR-related genes and IDD. Key genes were further validated using independent datasets and single-cell RNA sequencing data. A total of 26 UPR-related differentially expressed genes were identified, and protein–protein interaction network analysis with hub gene screening highlighted IRF1 , PRKD1 , CCND1 , and PDLIM1 as central regulators. Two-sample Mendelian randomization confirmed the causal associations of IRF1 and PRKD1 with IDD risk. Immune infiltration analysis revealed significant correlations between UPR-related genes and the activity of macrophages and T cells. Single-cell RNA sequencing further validated the differential expression and cell-type specificity of IRF1 and PRKD1 in degenerated nucleus pulposus tissues. This integrative multi-omics and Mendelian randomization study identifies IRF1 and PRKD1 as UPR-related drivers of IDD. These findings provide potential biomarkers and therapeutic targets for IDD management.